Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.
about
HIV infection and older Americans: the public health perspectiveT-cell aging in rheumatoid arthritisFrailty, HIV infection, and mortality in an aging cohort of injection drug usersThe clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefitClosing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaDeclines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, CanadaSingle DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsHIV-related mortality among adults (≥18 years) of various Hispanic or Latino subgroups – United States, 2006–2010Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.Employing human rights frameworks to realize access to an HIV cure.DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS.A pandemic of the poor: social disadvantage and the U.S. HIV epidemic.Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting.Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.Patient demographic and health factors associated with frequent use of emergency medical services in a midsized city.Frailty and Pre-Frailty in a Contemporary Cohort of HIV-Infected AdultsNon-AIDS-Defining Malignancies in the HIV-Infected PopulationHIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited CohortsResource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency departmentDisparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.HIV infection, inflammation, immunosenescence, and aging.Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes.Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques.Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, CanadaHealth status of HIV-infected women entering care: baseline medical findings from the women of color initiativeNeurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.Linkage to care for HIV-infected heterosexual men in the United StatesMain partner factors associated with worse adherence to HAART among women in Baltimore, Maryland: a preliminary studyAscertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designThe lifetime medical cost savings from preventing HIV in the United States.Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition.Influence of residential segregation on survival after AIDS diagnosis among non-Hispanic blacks.Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIVCancer screening in patients infected with HIV.Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.
P2860
Q26858824-AA34A073-EEAA-4967-8A24-A4886E8DE3C0Q26859971-175DFBB6-1BC4-41CE-9F09-ACBCB12AB0E0Q28485898-01FFC251-2C69-4F9F-B346-3D2A98DA8F26Q28535156-63074395-0642-430B-B5A5-9C00E3A4A65DQ28537704-891CE572-2E97-4A25-ABBB-3522EE2BFD13Q28610686-2FEB20B3-5F3E-42B5-86E6-D9DE4F672475Q28730050-F9850085-AE5E-4A8B-8E8A-2458509B421AQ29248882-BD28AFC2-EA4A-4F63-8459-D340C60D8FC8Q30248351-17A424ED-B921-49FB-A0BE-2229B26B6478Q30252460-4AD4C89B-EB8E-48AE-BB11-265A1A0903B9Q30381361-CCEA19A0-2DF5-4CF9-A3AC-64D6DEDB18EFQ30408029-DBC45CD0-DABF-4385-8F9E-E334A0EAE70CQ30430745-FCC615BD-BF3D-4A79-9EE9-E98C0E2D0155Q30666487-CBAD4166-5BC0-4EB9-A76F-1F95167D2920Q33640329-59F2D52C-4C47-4234-BD2C-E81BE22DF34BQ33640486-079036F3-B863-4A45-B689-92B9589A03C3Q33777223-01E7614C-395B-4F82-9806-B2EE5FEE5E00Q33813894-4B50254E-B884-43FC-90D9-EA003FDACD01Q33859370-9E42BF4C-57E4-4ED6-B875-D4ECCF6C5A6EQ33907350-D7AEDF9E-F05B-4D4E-A44E-78298213405EQ34055648-019E169B-4B56-4070-9EB1-8298B4287001Q34104857-E6847934-94EF-49ED-A1A0-8CB4C5E6B0A7Q34150710-E23E0277-B2A4-4B93-B364-41F13CEA7B28Q34455423-A854232D-4B39-42D4-86A2-798C364CECD7Q34459345-837AE7F2-2C77-401F-B185-75C4CE989BCCQ34596417-615F3027-A4A6-4BFB-84D3-65F897DF2A10Q34667707-3D31C6A7-EB63-46F3-93A4-0FC00DB2AF1EQ34776035-4E26509C-F5BE-4F37-AA37-AA92AE20AD4FQ34811502-8FFAA483-B180-4376-880B-21D20C6C59BFQ35003408-95E8A1E6-E9DE-421D-91C0-1C1B3ADCA763Q35019900-5AFAF632-1B54-402E-ADB1-E97E108B1484Q35100296-C1EC288D-31C2-4085-8BB7-3649A8CE2FE7Q35150425-28F18300-289C-4BD7-846D-C0FF0EC055B5Q35177401-1C4D3634-FA45-42C3-8B39-35D3BD8E070DQ35316315-6EECF4C7-B725-466D-A8FB-8D2B9C4516BCQ35488888-40641F88-99B0-4E12-9E03-BF1896F6C6F9Q35556833-4B93A903-2D30-4A02-8E6E-8F3D743486ACQ35836811-AA46D485-2F5B-4423-840A-1DE61851FB09Q35838509-1066815B-2EE5-4AFF-9853-D027786CE4E2Q35875093-9B4856C1-F930-4C88-883B-F02A84882F40
P2860
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Racial and sex disparities in ...... ion of antiretroviral therapy.
@en
Racial and sex disparities in ...... ion of antiretroviral therapy.
@nl
type
label
Racial and sex disparities in ...... ion of antiretroviral therapy.
@en
Racial and sex disparities in ...... ion of antiretroviral therapy.
@nl
prefLabel
Racial and sex disparities in ...... ion of antiretroviral therapy.
@en
Racial and sex disparities in ...... ion of antiretroviral therapy.
@nl
P2093
P2860
P50
P921
P356
P1476
Racial and sex disparities in ...... tion of antiretroviral therapy
@en
P2093
Bruce R Schackman
John J Chiosi
Kelly A Gebo
Perrin L Hicks
Richard D Moore
Sara N Sadownik
Wendy H Aaronson
P2860
P304
P356
10.1086/644772
P407
P577
2009-11-01T00:00:00Z